I think your preface to the question sort of answers the question. Companies invest in countries for, I'm sure, lots of different reasons, including the profit that they can make in that country.
The pharmaceutical industry undertook certain obligations in the North American Free Trade Agreement, as I'm sure you know, regarding their investment in Canada, and they have never reached the level of commitment that they made in the agreement. I don't know all the reasons why they do or don't invest in a country.
I think there are reasons that have to do with their profit levels. I know that in some countries in Europe, companies such as Sanofi, for example, have pushed back against regulations in price controls and have threatened to pull their production out of those countries. They haven't done it, so in spite of the fact that countries will implement stronger regulations and guidelines, they continue to invest. I think it has to do with lots of different considerations, and I'm not saying that I know what they all are.
What I do know is that Canada has the capacity within our own country.... We have the scientists. We have the capacity within our academic sector and scientific sector to do the type of research that's needed to support the development of drugs. I'm not saying that we have to do it without the pharmaceutical industry, but I think that we have the capacity to do that. We frame the question as if we will not be able to do it if the pharmaceutical industry doesn't invest. I question whether that's the case.